Skip to content
Journal article

Intervariability and intravariability of bone morphogenetic proteins in commercially available demineralized bone matrix products.

Bae H, Zhao L, Kanim L, Wong P, Delamarter R, Dawson E...(+6 more)

Spine, vol. 31, issue 12 (2006) pp. 1299-306; discussion 1307-8

  • 43

    Readers

    Mendeley users who have this article in their library.
  • 81

    Citations

    Citations of this article.
  • N/A

    Views

    ScienceDirect users who have downloaded this article.
Sign in to save reference

Abstract

Enzyme-linked immunosorbent assay was used to detect bone morphogenetic proteins (BMPs) 2, 4, and 7 in 9 commercially available ("off the shelf") demineralized bone matrix (DBM) product formulations using 3 different manufacturer's production lots of each DBM formulation.

Author-supplied keywords

  • Biological Agents
  • Biological Agents: chemistry
  • Bone Demineralization Technique
  • Bone Matrix
  • Bone Matrix: chemistry
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Protein 4
  • Bone Morphogenetic Protein 7
  • Bone Morphogenetic Proteins
  • Bone Morphogenetic Proteins: analysis
  • Enzyme-Linked Immunosorbent Assay
  • Growth Differentiation Factor 2
  • Growth Differentiation Factors
  • Humans
  • Osmolar Concentration
  • Transforming Growth Factor beta
  • Transforming Growth Factor beta: analysis

Find this document

Get full text

Cite this document

Choose a citation style from the tabs below